×
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
NASDAQ:MASI

Masimo Stock Forecast, Price & News

$135.90
+5.23 (+4.00%)
(As of 07/1/2022 12:00 AM ET)
Add
Compare
Today's Range
$130.75
$136.14
50-Day Range
$112.97
$143.50
52-Week Range
$112.07
$305.21
Volume
456,474 shs
Average Volume
917,917 shs
Market Capitalization
$7.54 billion
P/E Ratio
35.12
Dividend Yield
N/A
Price Target
$179.60

Masimo Stock Forecast (MarketRank)

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
32.2% Upside
$179.60 Price Target
Short Interest
Healthy
5.67% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.86
Upright™ Environmental Score
News Sentiment
0.47mentions of Masimo in the last 14 days
Based on 14 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
15.62%
From $4.61 to $5.33 Per Share

Overall MarketRank

MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.

2.50 out of 5 stars

Medical Sector

158th out of 1,429 stocks

Electromedical Equipment Industry

3rd out of 30 stocks

30 days | 90 days | 365 days | Advanced Chart

Receive MASI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Masimo and its competitors with MarketBeat's FREE daily newsletter.

Masimo logo

About Masimo (NASDAQ:MASI)

Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index. It offers SedLine brain function monitoring technology to measure the brain's electrical activity by detecting EEG signals; capnography and gas monitoring products comprising external plug-in-and-measure capnography and gas analyzers, integrated modules, handheld capnograph and capnometer devices, and capnography sampling lines; O3 regional oximetry for tissue oxygen saturation measurement; and hemodynamic monitoring solutions. Its Masimo Hospital Automation platform includes Patient SafetyNet, Patient SafetyNet surveillance, Kite, UniView, Replica, UniView : 60, and MyView. It offers connectivity devices; and nasal high flow ventilation and neuromodulation solutions. It provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and non-medical/consumer products through e-commerce site, masimopersonalhealth.com. The company was incorporated in 1989 and is headquartered in Irvine, California.

MASI Stock News Headlines

Trading With A Small Account?
If you’ve been told it’s not doable, you’ve been lied to! Hi, I’m pro-trader Chuck Hughes and I grew my once tiny investment into an empire! If you want to do the same–or simply want to feel more secure in your finances–”Options Trading Made Easy” is the guide you need. Get a copy here!
This Options Expert is Giving Everything Away!
Trading champion Chuck Hughes has exposed the strategies of successful traders and handing them over to new traders like you! His guide “Options Trading Made Easy” now comes with a Trade of the Day from Chuck himself to help you develop a profitable, pro-level trading account!
See More Headlines

Industry, Sector and Symbol

Industry
Electromedical equipment
Sub-Industry
Health Care Equipment
Sector
Medical
Current Symbol
NASDAQ:MASI
CUSIP
57479510
Employees
6,200
Year Founded
1989

Company Calendar

Last Earnings
5/03/2022
Today
7/02/2022
Next Earnings (Estimated)
7/26/2022
Fiscal Year End
12/31/2022

Price Target and Rating

Average Stock Price Forecast
$179.60
High Stock Price Forecast
$295.00
Low Stock Price Forecast
$130.00
Forecasted Upside/Downside
+32.2%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.5
Research Coverage
6 Analysts

Profitability

Net Income
$229.65 million
Pretax Margin
21.58%

Debt

Sales & Book Value

Annual Sales
$1.24 billion
Cash Flow
$4.71 per share
Book Value
$28.00 per share

Miscellaneous

Free Float
50,120,000
Market Cap
$7.54 billion
Optionable
Optionable
Beta
0.98

Social Links















Masimo Frequently Asked Questions

Should I buy or sell Masimo stock right now?

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Masimo in the last twelve months. There are currently 3 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" Masimo stock.
View analyst ratings for Masimo
or view top-rated stocks.

What is Masimo's stock price forecast for 2022?

6 brokers have issued 1 year target prices for Masimo's stock. Their MASI stock forecasts range from $130.00 to $295.00. On average, they expect Masimo's share price to reach $179.60 in the next twelve months. This suggests a possible upside of 32.2% from the stock's current price.
View analysts' price targets for Masimo
or view top-rated stocks among Wall Street analysts.

How has Masimo's stock price performed in 2022?

Masimo's stock was trading at $292.78 at the beginning of 2022. Since then, MASI shares have decreased by 53.6% and is now trading at $135.90.
View the best growth stocks for 2022 here
.

When is Masimo's next earnings date?

Masimo is scheduled to release its next quarterly earnings announcement on Tuesday, July 26th 2022.
View our earnings forecast for Masimo
.

How were Masimo's earnings last quarter?

Masimo Co. (NASDAQ:MASI) released its quarterly earnings results on Tuesday, May, 3rd. The medical equipment provider reported $0.93 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.92 by $0.01. The medical equipment provider earned $304.24 million during the quarter, compared to analyst estimates of $308.04 million. Masimo had a trailing twelve-month return on equity of 15.46% and a net margin of 17.91%. The company's revenue was up 1.7% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.90 earnings per share.
View Masimo's earnings history
.

What guidance has Masimo issued on next quarter's earnings?

Masimo issued an update on its FY 2022 earnings guidance on Monday, May, 9th. The company provided EPS guidance of $4.46-$4.73 for the period, compared to the consensus estimate of $4.16. The company issued revenue guidance of $2.00 billion-$2.06 billion, compared to the consensus revenue estimate of $1.60 billion.

Who are Masimo's key executives?

Masimo's management team includes the following people:

What is Joe E. Kiani's approval rating as Masimo's CEO?

136 employees have rated Masimo CEO Joe E. Kiani on Glassdoor.com. Joe E. Kiani has an approval rating of 90% among Masimo's employees.

What other stocks do shareholders of Masimo own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Masimo investors own include NVIDIA (NVDA), Netflix (NFLX), Shopify (SHOP), Okta (OKTA), PayPal (PYPL), Alibaba Group (BABA), Mastercard (MA), Trade Desk (TTD), Walt Disney (DIS) and Twilio (TWLO).

What is Masimo's stock symbol?

Masimo trades on the NASDAQ under the ticker symbol "MASI."

How do I buy shares of Masimo?

Shares of MASI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Masimo's stock price today?

One share of MASI stock can currently be purchased for approximately $135.90.

How much money does Masimo make?

Masimo (NASDAQ:MASI) has a market capitalization of $7.54 billion and generates $1.24 billion in revenue each year. The medical equipment provider earns $229.65 million in net income (profit) each year or $3.869990 on an earnings per share basis.

How many employees does Masimo have?

Masimo employs 6,200 workers across the globe.

When was Masimo founded?

Masimo was founded in 1989.

How can I contact Masimo?

Masimo's mailing address is 52 DISCOVERY, IRVINE CA, 92618. The official website for Masimo is www.masimo.com. The medical equipment provider can be reached via phone at (949) 297-7000, via email at ekammerman@masimo.com, or via fax at 949-297-7001.

This page (NASDAQ:MASI) was last updated on 7/2/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.